Literature DB >> 32548152

Role of Hiraoka's transurethral detachment of the prostate combined with biopsy of the peripheral zone during the same session in patients with repeated negative biopsies in the diagnosis of prostate cancer.

Chun-Yu Pan1, Bin Wu1, Zi-Chuan Yao1, Xian-Qing Zhu1, Yun-Zhong Jiang1, Song Bai2.   

Abstract

BACKGROUND: Persistent suspicion of prostate cancer (PCa) due to a rising prostate-specific antigen (PSA) level after repeated negative biopsies is a serious challenge in clinical practice. AIM: To determine the role of Hiraoka's transurethral detachment of the prostate (TUDP) combined with biopsy of the peripheral zone during the same session in patients with repeated negative biopsies in the diagnosis of PCa.
METHODS: We retrospectively evaluated the records of 10 patients who were eligible for inclusion in our hospital between December 2012 and August 2017. Patient demographics, a family history of PCa, the number of biopsies, prostate volume, pathological examination, and perioperative PSA level were obtained.
RESULTS: Two of 10 patients were pathologically diagnosed with PCa after surgery; the Gleason scores were 4 + 4 and 4 + 3, respectively. Both patients subsequently underwent laparoscopic radical prostatectomy. The median PSA levels preoperatively, and 3 mo and 1 year postoperatively in the other eight patients who were diagnosed with benign prostate hyperplasia after surgery were 19.10 ng/mL, 1.10 ng/mL, and 1.15 ng/mL, respectively. The adjusted P values of the 3-mo and 1-year post-operative PSA level vs pre-operative PSA level were 0.003 and 0.026, respectively. None of the patients had increased PSA levels or PCa detected after a median 35 mo of follow-up.
CONCLUSION: TUDP combined with peripheral zone biopsy may improve the detection rate of PCa in patients with repeated negative biopsies. The PSA level declined rapidly in patients who had negative pathological examinations after TUDP, which remained stable 1 year after surgery. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Biopsy; Hiraoka’s transurethral detachment of the prostate; Prostate cancer; Prostate-specific antigen; Transurethral detachment of prostate; Transurethral resection of the prostate

Year:  2020        PMID: 32548152      PMCID: PMC7281050          DOI: 10.12998/wjcc.v8.i11.2219

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  24 in total

1.  Trial of complete detachment of the whole prostate lobes in benign prostate hyperplasia by transurethral enucleation of the prostate.

Authors:  Yasunori Hiraoka; Yuji Shimizu; Kazuya Iwamoto; Hirohumi Takahashi; Hiroyuki Abe
Journal:  Urol Int       Date:  2007       Impact factor: 2.089

2.  Health perceptions in patients who undergo screening and workup for prostate cancer.

Authors:  David A Katz; David F Jarrard; Colleen A McHorney; Stephen L Hillis; Donald A Wiebe; Dennis G Fryback
Journal:  Urology       Date:  2007-02       Impact factor: 2.649

3.  Does transurethral resection of the prostate facilitate detection of clinically significant prostate cancer that is missed with systematic sextant and transition zone biopsies?

Authors:  Hiroshi Kitamura; Naoya Masumori; Yasushi Tanuma; Masahiro Yanase; Naoki Itoh; Atsushi Takahashi; Taiji Tsukamoto; Hideki Adachi; Hiroshi Hotta
Journal:  Int J Urol       Date:  2002-02       Impact factor: 3.369

4.  Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.

Authors:  Brian T Helfand; Christopher B Anderson; Angela Fought; Dae Y Kim; Ashish Vyas; Kevin T McVary
Journal:  Urology       Date:  2009-05-09       Impact factor: 2.649

5.  Prospective study of the role of transurethral resection of the prostate in patients with an elevated prostate-specific antigen level, minor lower urinary tract symptoms, and proven bladder outlet obstruction.

Authors:  Koenraad van Renterghem; Gommert Van Koeveringe; Ruth Achten; Philip van Kerrebroeck
Journal:  Eur Urol       Date:  2008-06-26       Impact factor: 20.096

6.  The worldwide epidemiology of prostate cancer: perspectives from autopsy studies.

Authors:  Gabriel P Haas; Nicolas Delongchamps; Otis W Brawley; Ching Y Wang; Gustavo de la Roza
Journal:  Can J Urol       Date:  2008-02       Impact factor: 1.344

7.  Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies.

Authors:  Richard Zigeuner; Luigi Schips; Katja Lipsky; Marko Auprich; Michael Salfellner; Peter Rehak; Karl Pummer; Gerhart Hubmer
Journal:  Urology       Date:  2003-11       Impact factor: 2.649

8.  Preoperative clinical factors for diagnosis of incidental prostate cancer in the era of tissue-ablative surgery for benign prostatic hyperplasia: a korean multi-center review.

Authors:  Changhee Yoo; Cheol Young Oh; Se Joong Kim; Sun Il Kim; Young Sig Kim; Jong Yeon Park; Do Hwan Seong; Yun Seob Song; Won Jae Yang; Hyun Chul Chung; In Rae Cho; Sung Yong Cho; Sang Hyeon Cheon; Sungjoon Hong; Jin Seon Cho
Journal:  Korean J Urol       Date:  2012-06-19

Review 9.  A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies.

Authors:  Koenraad van Renterghem; Gommert Van Koeveringe; Ruth Achten; Philip van Kerrebroeck
Journal:  Int Urol Nephrol       Date:  2009-06-03       Impact factor: 2.370

10.  Incidental prostate cancer in transurethral resection of the prostate specimens in the modern era.

Authors:  Brandon Otto; Christopher Barbieri; Richard Lee; Alexis E Te; Steven A Kaplan; Brian Robinson; Bilal Chughtai
Journal:  Adv Urol       Date:  2014-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.